🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "focused action to deal with household expense challenges" in the forthcoming Budget.

Speaking to media outlets, she emphasized that reducing inflation is a collective responsibility of both the government and the Bank of England.

The UK's inflation rate is expected to be the highest among the Group of Seven developed nations this calendar year and the following year.

Possible Utility Cost Measures

Reports indicate the administration could intervene to reduce utility costs, such as by cutting the present 5% level of VAT charged on energy.

A further approach is to lower some of the policy costs currently added to household expenses.

Budgetary Constraints and Analyst Predictions

The government will receive the next assessment from the official forecaster, the OBR, on Monday, which will clarify how much room there is for these measures.

The expectation from the majority of economists is that the Chancellor will have to announce tax increases or expenditure reductions in order to fulfill her self-imposed borrowing rules.

Earlier on the same day, analysis suggested there was a £22 billion gap for the chancellor to fill, which is at the more modest range of forecasts.

"There's a joint job between the Bank of England and the administration to continue tackling some of the causes of price increases," Reeves informed reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Commitments and International Issues

While a great deal of the attention has been on expected tax increases, the Treasury chief said the latest data from the fiscal watchdog had not changed her commitment to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She attributed an "uncertain world" with increasing international and commercial concerns for the Budget tax moves, likely to be focused on those "wealthiest."

International Economic Tensions

Commenting on worries about the UK's economic relations with the Asian nation she said: "The UK's national security always take priority."

Last week's statement by Chinese authorities to increase trade restrictions on rare earths and other resources that are key for high-technology production led American leader the US President to propose an further 100% import tax on goods from the Asian country, raising the risk of an full-scale trade war between the two global powers.

The US Treasury Secretary described China's action "economic coercion" and "a international production power grab."

Questioned on considering the American proposal to join its dispute with China, Reeves said she was "extremely troubled" by Chinese actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "harmful for the international commerce and causes further challenges."

"It is my opinion there are areas where we should address Chinese policies, but there are also significant opportunities to export to China's economy, including financial services and other areas of the economic system. We've got to get that equilibrium correct."

The chancellor also confirmed she was working with other major economies "on our own critical minerals approach, so that we are less reliant."

NHS Medicine Costs and Funding

Reeves also admitted that the price the NHS pays for pharmaceuticals could rise as a consequence of current discussions with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or abandoning projects in the UK, with some blaming the modest returns they are obtaining.

Recently, the government science advisor said the price the health service spends on drugs would must rise to stop companies and pharmaceutical investment departing from the United Kingdom.

Reeves informed media: "We have seen because of the pricing regime, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other EU nations."

"We want to guarantee that individuals receiving treatment from the National Health Service are able to obtain the finest critical medicines in the globe. And so we are looking at this situation, and... seeking to secure additional capital into Britain."